- Home
- BV vs PHAT Comparison
BV vs PHAT Comparison
Compare BV & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BV | PHAT |
|---|---|---|
| Founded | 1939 | 2018 |
| Country | United States | United States |
| Employees | N/A | 427 |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 894.0M |
| IPO Year | 2018 | 2019 |
Fundamental Metrics
Financial Performance| Metric | BV | PHAT |
|---|---|---|
| Price | $13.75 | $11.56 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | $14.30 | ★ $19.50 |
| AVG Volume (30 Days) | 640.6K | ★ 898.5K |
| Earning Date | 05-06-2026 | 05-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 42.72 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $175,110,000.00 |
| Revenue This Year | $4.61 | $83.18 |
| Revenue Next Year | $1.93 | $61.43 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 216.93 |
| 52 Week Low | $11.06 | $2.21 |
| 52 Week High | $17.11 | $18.31 |
Technical Indicators
Market Signals| Indicator | BV | PHAT |
|---|---|---|
| Relative Strength Index (RSI) | 53.41 | 39.53 |
| Support Level | $12.62 | $10.65 |
| Resistance Level | $13.96 | $12.77 |
| Average True Range (ATR) | 0.46 | 0.87 |
| MACD | -0.01 | 0.09 |
| Stochastic Oscillator | 62.04 | 14.01 |
Price Performance
Historical ComparisonAbout BV BrightView Holdings Inc.
BrightView Holdings Inc is a provider of commercial landscaping services in the United States. The company provides commercial landscaping services, landscape maintenance, and enhancements to tree care and landscape development. It operates through two segments namely Maintenance Services, and Development Services. The Maintenance Services are self-performed through a national branch network and are route-based in nature. It includes mowing, gardening, mulching and snow removal, water management etc. And Development Services are comprised of sophisticated design, coordination, and installation of landscapes at recognizable corporate, athletic, and university complexes. The company generates a majority of its revenue from Maintenance Services.
About PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.